Qiming U.S. Healthcare Fund II L.P. 13D/13G Filings for Jasper Therapeutics, Inc. (JSPR)

Qiming U.S. Healthcare Fund II L.P. 13D and 13G filings for Jasper Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-10-01
4:13 pm
Purchase
2021-09-2413GJasper Therapeutics, Inc.
JSPR
Qiming U.S. Healthcare Fund II L.P.585,298
16.000%
585,298increase
(New Position)
Filing